IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $908,000 | +16.9% | 46,666 | 0.0% | 0.01% | +20.0% |
| Q4 2017 | $777,000 | -18.0% | 46,666 | 0.0% | 0.01% | +25.0% |
| Q3 2017 | $947,000 | +54.7% | 46,666 | +22.8% | 0.00% | -20.0% |
| Q2 2017 | $612,000 | -7.6% | 37,995 | -27.3% | 0.01% | -16.7% |
| Q1 2017 | $662,000 | -4.5% | 52,295 | 0.0% | 0.01% | -14.3% |
| Q4 2016 | $693,000 | -44.1% | 52,295 | 0.0% | 0.01% | -46.2% |
| Q3 2016 | $1,239,000 | -12.4% | 52,295 | +6.5% | 0.01% | -18.8% |
| Q2 2016 | $1,415,000 | -8.1% | 49,095 | +2.1% | 0.02% | -5.9% |
| Q1 2016 | $1,540,000 | -23.2% | 48,095 | +2.6% | 0.02% | +6.2% |
| Q4 2015 | $2,005,000 | -23.9% | 46,895 | -37.3% | 0.02% | -33.3% |
| Q3 2015 | $2,634,000 | -44.2% | 74,795 | -27.2% | 0.02% | -29.4% |
| Q2 2015 | $4,719,000 | -19.4% | 102,758 | -17.8% | 0.03% | -20.9% |
| Q1 2015 | $5,857,000 | +48.3% | 124,958 | +0.2% | 0.04% | +65.4% |
| Q4 2014 | $3,950,000 | +35.5% | 124,674 | +1.4% | 0.03% | +36.8% |
| Q3 2014 | $2,916,000 | -32.0% | 122,974 | -14.0% | 0.02% | -26.9% |
| Q2 2014 | $4,291,000 | +24.1% | 143,074 | +9.3% | 0.03% | +18.2% |
| Q1 2014 | $3,458,000 | -12.7% | 130,900 | -16.9% | 0.02% | -12.0% |
| Q4 2013 | $3,960,000 | +25.3% | 157,500 | +2.2% | 0.02% | +25.0% |
| Q3 2013 | $3,161,000 | +29.9% | 154,100 | +26.3% | 0.02% | +5.3% |
| Q2 2013 | $2,434,000 | – | 122,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |